354 |
TAVR-in-TAVR: Planning and Optimizing the Procedure |
Karl Poon |
Apr. 19. 24 |
353 |
Ultra-Minimalist TAVR: Novel Strategy for a Quick Procedure and Short Hospital Stay |
James Flaherty |
Apr. 19. 24 |
352 |
No Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight from the OCEAN-TAVI Registry |
Shinichi Shirai |
Apr. 19. 24 |
351 |
Smart TAVR Valve Selection in Asian Patients With Different Anatomy: What We Should More Consider? |
Yohei Ohno |
Apr. 19. 24 |
350 |
TAVR in Moderate AS with Heart Failure |
Michael Kang-Yin Lee |
Apr. 19. 24 |
349 |
TAVR Explant: The NEXT Challenging Issue in Lifetime TAVR Management |
Tsuyoshi Kaneko |
Apr. 19. 24 |
348 |
TAVR-in-TAVR: The NEXT Challenging Issue in Lifetime TAVR Management |
Philippe Garot |
Apr. 19. 24 |
347 |
Essentials of Lifetime Management of Aortic Disease: Updated and Novel Points in 2024 |
Eberhard Grube |
Apr. 19. 24 |
346 |
Beginner's Perspective of TEER |
Yoon Seok Koh |
Aug. 12. 22 |
345 |
Real World Experience Sharing with ACURATE neo2 |
Won-Keun Kim |
Aug. 01. 22 |